跳至主要内容
临床试验/NCT03650790
NCT03650790已完成不适用

Diyarbakir Women's and Children's Diseases Hospital

Diyarbakir Women's and Children's Diseases Hospital2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年9月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
CTRP 9 level in preeclamptic pregnancies

研究概览

简要总结

The complement C1q tumor necrosis factor-associated protein-9 (CTRP-9), which is responsible for regulating cardiovascular and metabolic functions, increases vascular relaxation by pathway dependent on AMPK / endothelial nitric oxide synthesis (eNOS). The aim of this study was to investigate CTRP-9 levels in pregnant women with preeclampsia.

详细描述

The most important reason for the development of preeclampsia is the problem of trophoblastinvasion and consequent formation and development of placenta is not healthy

Cytokines are regulatory molecules that have effects on cell functions.Cytokines are molecules that also regulate endothelial functions. Placenta formation and widespread endothelial damage are under the influence of cytokines.

Therefore, there may be important links between impairment or imbalance in cytokine release and function and the formation of preeclampsia.Nitric oxide (NO) is a biologic enzyme that is synthesized by nitric oxide synthase (NOS) from the amino acid of L-arginine and exists in all mammals.

e(NOS) is the three isoforms of NO. It is known that NO is a major vasodilator of pregnancy, inhibiting platelet and leukocyte aggregation.There was a decrease in NO levels in preeclamptic patients.

The CqP / TNF Binding Protein (CTRP) family consists of 15 members, and is synthesized in many organs outside the body of fat.CTRP9 is predominantly excreted in fat tissue, and levels in circulation are reduced in patients with diabetes and obesity.Many studies have shown that CTRP9 exerts beneficial effects on metabolic and cardiovascular homeostasis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
15 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women who are ages 15-40
  • BMI ≥35 kg/m2 and BMI<25 KG/m2 pregnants
  • The clinical diagnosis of preeclampsia will follow the current criteria outlined by ACOG 10
  • > 20 th weeks of pregnancy

排除标准

  • A previously known chronic metabolic disease (diabetes, pregestational dyslipidemia, hypertension,)
  • collagen vascular diseases,
  • inflammatory bowel disease
  • chronic inflammatory conditions,

研究组 & 干预措施

preeclamptic obese pregnancy

Active Comparator

CTRP 9 level will be assessed by 40 obese preeclamptic gestational ELISA methods that meet the latest ACOG criteria.

干预措施: Blood test (Diagnostic Test)

preeclamptic non-obese pregnancy

Active Comparator

CTRP 9 level will be assessed by 40 non-obese preeclamptic gestational ELISA methods that meet the latest ACOG criteria.

干预措施: Blood test (Diagnostic Test)

normal pregnancy

Active Comparator

CTRP 9 level will be assessed by 40 normal gestational ELISA methods

干预措施: Blood test (Diagnostic Test)

结局指标

主要结局

CTRP 9 level in preeclamptic pregnancies

时间窗: 3 months

Blood samples were taken from patients with preeclampsia. The diagnosis was made when the arterial blood pressure was above 140/90 mm / Hg within 6 hours and was accompanied by proteinuria (\> 300 milligrams in a sample) with high blood pressure and number of patients with proteinuria (ACOG criteria)

次要结局

未报告次要终点

研究者

发起方
Diyarbakir Women's and Children's Diseases Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Şerif AKSİN

specialist doctor

Diyarbakir Women's and Children's Diseases Hospital

研究点 (2)

Loading locations...

相似试验